If you need help paying for your child’s treatment with REMICADE®, you’re not alone. Many people need help paying for their family’s medications.
If your doctor thinks REMICADE® is the right choice for your child and you need assistance with your medication out-of-pocket costs, you may be eligible for the RemiStart® Patient Rebate Program.
If you have already participated in RemiStart®, you may be eligible for continuing support through the RemiStart® Extended Access Program.
Based on your eligibility, RemiStart® may provide a rebate for your child’s medication out-of-pocket costs, including deductible, co-pay, and co-insurance, for up to 12 months, 8 infusions, or $4,400 maximum benefit. The cost of IV infusion services is not covered by this program.
You can find out more about eligibility requirements, restrictions, and program enrollment by visiting RemiStart.com [1].
If you have already participated in RemiStart® and you have used up the program benefits, you may qualify for continuing support from the RemiStart® Extended Access Program.
You can find out more about your eligibility for this program, restrictions, and the enrollment process by visiting RemiStart.com [1].
Only your doctor can recommend a course of treatment after checking your health condition. REMICADE® (infliximab) can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections caused by viruses, fungi or bacteria that have spread throughout the body, including tuberculosis (TB) and histoplasmosis. Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with REMICADE®.
Unusual cancers have been reported in children and teenage patients taking TNF-blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in teenage or young adult males with Crohn’s disease or ulcerative colitis who were taking REMICADE® and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including REMICADE®, the chances of getting lymphoma or other cancers may increase.
You should discuss any concerns about your health and medical care with your doctor.
What should I tell my doctor before I take REMICADE®?
You should let your doctor know if you have or ever had any of the following:
Also tell your doctor if you:
What should I watch for and talk to my doctor about before or while taking REMICADE®?
The following serious (sometimes fatal) side effects have been reported in people taking REMICADE®.
You should tell your doctor right away if you have any of the signs listed below:
For more information, please download the Full Prescribing Information and Medication Guide and discuss it with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
Links:
[1] http://www.remistart.com/
[2] http://www.remicade.com/pediatric-ulcerative-colitis/support-insurance-faqs